Introduction {#sec1}
============

The development of molecular motors and switches holds great promise for the field of molecular machinery.^[@ref1]^ Continuous research efforts in the last three decades culminated in the development of a great variety of molecular machines able to perform functions at the nanoscale.^[@ref2]^ In 1999, the first light-driven unidirectional molecular motor based on overcrowded alkenes was developed by our group.^[@ref3]^ These systems, which use light as fuel to accomplish unidirectional 360° rotation around an axle involving a four-step mechanism, are among the most promising classes of molecular motors and switches to be applied in molecular nanotechnology ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Four-Step Operating Mechanism Leading to Unidirectional Rotation of the Rotor (Red Upper Half) Relative to the Stator (Black Lower Half) Powered by Light (Depicted for the *R* Enantiomer\
)](jo-2017-00852d_0005){#sch1}

Focusing on the individual steps of the rotary cycle, a photochemical *E*--*Z* isomerization transforms the thermodynamically favored isomer, for example, (*P*)-(*R*)-**1** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}), into a metastable isomer, that is (*M*)-(*R*)-**1**. Subsequently, this photogenerated isomer undergoes a conformational change, usually referred to as the thermal helix inversion (THI), where the naphthalene moiety slips over the fluorenyl stator in order to reform the original isomer. The result of the energetically uphill photoisomerization and thermodynamically downhill THI is a 180° counterclockwise rotation of the upper half relative to the lower half. Another photochemical step followed by a THI completes the unidirectional 360° rotation around the double bond. Continuous irradiation at high enough temperature to allow THI then leads to repetitive unidirectional rotation. These molecular motors have been used for dynamic control of function.^[@ref4]^ In the applications of these systems their enantiopurity is paramount. The configuration at the stereogenic center dictates the direction of rotation; hence, a collection of molecular motors rotates only in the same direction if the sample is enantiomerically pure. In our efforts to construct molecular machines and smart materials based on rotary molecular motors, access to enantiopure functionalizable compounds is often a necessity. We recently developed a method for the asymmetric synthesis of first-generation molecular motors using a gold-catalyzed enantioselective protonation and an ee-enhancing McMurry coupling.^[@ref5]^ The enantioselective synthesis of second-generation molecular motors, however, was found to be more challenging. The Barton--Kellogg (BK) reaction is normally used to construct the sterically hindered double bond (the rotary axle), but it was found that the transformation of the precursor ketone into either thioketone or hydrazone (followed by the oxidation to the corresponding diazo compound) is accompanied by racemization of the stereogenic α center, resulting in racemic product, when starting from enantiopure ketones ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref6]^

![Synthetic Strategy toward Enantiopure Molecular Motors](jo-2017-00852d_0006){#sch2}

In 2010, a method was developed to reduce the loss of optical purity during the formation of the hydrazone and diazo precursor.^[@ref6]^ Using bis-TBS hydrazine, Sc(OTf)~3~, and short reaction times, the racemization during hydrazone formation could be suppressed to some extent (starting with 98% ee, product with 86% ee is obtained). Alternatively, the groups of Lautens^[@ref7]−[@ref9]^ and Tietze^[@ref10]−[@ref15]^ developed elegant palladium-catalyzed cascade reactions to access sterically hindered tetrasubstituted alkenes, but many structural motifs commonly found in molecular motors are still unattainable with these methods. Considering the importance of ready access to optically active molecular motors, we explored new ways to synthesize these compounds without having to rely on chiral HPLC separations. It was reasoned from previous experience that the racemization of either chiral hydrazone or thione was difficult to avoid. Therefore, it was opted to structurally modify the molecular motor in such a way that racemization (or epimerization) of the α stereocenter during the synthesis is disfavored. In the design of a new class of molecular motors there are generally two considerations: (i) the modification should not impair the proper functioning of the molecular motor and (ii) the modified motor should contain an α stereocenter. Previously, molecular motors were studied in which the stereocenter was moved from the α position to the β position, and although this change seems to be a good option to avoid racemization of the stereocenter, it was found that these resulting molecular rotors are not fully unidirectional.^[@ref16]^ It was reasoned that the introduction of an additional substituent at the β position with trans vicinal stereochemistry, while maintaining the α substituent, would disfavor epimerization during thioketone formation due to increased steric hindrance caused by the cis configuration of the α and β substituent, upon epimerization. Here, we show that the addition of a β substituent allows for the facile enantioselective synthesis of molecular motors based on overcrowded alkenes, and that this modification does not impair proper functioning of these motors.

Results and Discussion {#sec2}
======================

Density functional theory (DFT) (B3LYP 6/31G(d,p)) was used to predict the behavior of known molecular motor **1** and motors **2**--**4**, which were considered as potential synthetic targets ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### Calculated Gibbs Free Energies (DFT B3LYP (6-31G(d,p)) for Motors **1**--**4**

![](jo-2017-00852d_0010){#fx1}

  compd   Δ^⧧^*G*~THI~[a](#t1fn1){ref-type="table-fn"}   Δ^⧧^*G*~--THI~[a](#t1fn1){ref-type="table-fn"}   ΔΔ*G*[a](#t1fn1){ref-type="table-fn"},[b](#t1fn2){ref-type="table-fn"}
  ------- ---------------------------------------------- ------------------------------------------------ ------------------------------------------------------------------------
  **1**   88.5                                           102.1                                            13.5
  **2**   90.0                                           101.8                                            11.8
  **3**   87.4                                           97.8                                             10.4
  **4**   103.8                                          105.9                                            2.1

kJ/mol.

ΔΔ*G* between the metastable and the stable state.

It was found previously that the behavior of molecular motors could be accurately predicted using this method.^[@ref17]^ For each motor, the stable, metastable, and transition state (TS) for the THI were found by a potential energy scan (PES) using the semiempirical PM6 followed by a reoptimization with DFT. An energy diagram for **2** is given in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, and the calculated Gibbs free energies for the geometry-optimized structures for motors **1**--**4** are given in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

![Energy diagram for the THI of **2**.](jo-2017-00852d_0001){#fig1}

The free energy differences characterize the behavior of the motor. The Δ^⧧^*G*~THI~ is related to the speed of rotation in the forward direction, while Δ^⧧^*G*~--THI~ determines the speed of rotation in the backward direction. If the Gibbs free energy difference between the stable and metastable form is large (ΔΔ*G* \> 10 kJ/mol), as is the case for motors **1**--**3**, the THI in the forward direction is much faster, leading to unidirectional rotation. However, if the difference in stability between the stable and metastable isomer becomes small, as for motor **4**, the rate of the THI in the forward and backward reaction become comparable, with the consequence that the motor is not fully unidirectional in its rotation. This behavior has previously been observed for motors which lack an α substituent.^[@ref16]^ These calculations suggest that motor **2** and **3** would both function as unidirectional motors with comparable speed as the reported known motor **1**. On the basis of these calculations, it is anticipated that the introduction of a β substituent does not compromise the motor function, while it can avoid the loss of optical purity during the BK reaction.

The synthesis started with the commercially available alcohol **5** (96% ee) ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). The alcohol was converted following a literature procedure^[@ref18]^ into tris ester **6** employing a Mitsunobu reaction using triethylmethanetricarboxylate (TEMT) as nucleophile, with inversion of stereochemistry.^[@ref18]^ After saponification of **6**, the tris acid **7** was obtained, which was decarboxylated to afford acid **8** after purification by column chromatography (68% yield in three steps). Cyclization of acid **8** with TfOH afforded the corresponding ketone **9** in 96% ee, as determined by chiral SFC. Deprotonation of ketone **9** with LDA followed by the addition of either MeI or HMPA and *i*-PrI afforded ketones **10** and **11**, respectively ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Synthesis of Ketone **9**([@ref18])](jo-2017-00852d_0007){#sch3}

![Synthesis of Motors **2** and **3**](jo-2017-00852d_0008){#sch4}

Ketone **10** was obtained as a mixture of isomers (trans/cis 9:1) that could be separated after conversion to the thioketone stage (compound **12**) The thioketones **12** and **13** were prepared by the action of Lawesson's reagent (LR) and were coupled to 2,7-dibromodiazofluorene by stirring in THF at rt, affording a mixture of episulfide and the desired overcrowded alkene. 2,7-Dibromodiazofluorene was used instead of the unsubstituted diazofluorene for several reasons. First, unsubstituted diazofluorene readily dimerizes into bifluorenylidene, a compound which is difficult to separate from the desired product, and the introduction of bromine substituents suppresses this dimerization. Second, the bromo groups increase the crystallinity, allowing for facile recrystallization of the desired products. Finally, the bromine groups form nice handles for the introduction of functional groups in order to synthesize functional molecular motors. The mixture of alkene and episulfide, obtained after the BK reaction, was treated with hexamethylphosphorous triamine (HMPT) in THF to fully convert the episulfide into the corresponding alkene to afford **15** (96% ee) and **17** (96% ee). The ee of the starting alcohol **5** was 96% ee; thus, no loss in optical purity was detected during the synthesis of **15** and **17**. Furthermore, motors **15** and **17** were obtained enantiomerically pure (≥99% ee) after recrystallization from heptane. For the synthesis of the parent motors **2** and **3**, the bromine substituents were removed by halogen--lithium exchange with *n*-BuLi followed by quenching with CH~3~OH. X-ray crystallography was performed on **15** to confirm the absolute configuration ((*M*)-(*S*,*S*)-**15**) and relative stereochemistry. The two stereogenic methyl groups are positioned trans to each other, and *M* helicity is observed with an *S* absolute configuration at the α stereocenter ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [Figure S41](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)).

![X-ray structure of (*M*)-(*S*,*S*)-**15**. Ellipsoids set at 50% probability. Hydrogen atoms are omitted for clarity. (Left) Front view. (Right) Side view.](jo-2017-00852d_0002){#fig2}

With the products **2** and **3** in hand, the photochemical and subsequent thermal isomerization steps were studied. Irradiation of a solution of **2** in CH~2~Cl~2~ resulted in a red-shifted absorption spectrum, and clear isosbestic points were detected, indicative of the isomerization of the stable to the metastable form ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a).

![(a) Changes in UV/vis spectrum of a solution of **2** in CH~2~Cl~2~ upon irradiation at 365 nm. (b) Changes in CD spectrum of a solution of **2** in CH~2~Cl~2~ upon irradiation at 365 nm.](jo-2017-00852d_0003){#fig3}

UV/vis spectroscopy indicated that the metastable state thermally relaxes to the stable state, and the reaction rate of this process was followed at six temperatures (15--27.5 °C). Eyring analysis gave a Δ^⧧^*G* (20 °C) of 88.8 ± 1 kJ/mol for the THI of **2** ([Figure S39](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)), in close agreement with the DFT-predicted value of Δ^⧧^*G*~calc~ (20 °C) = 90.0 kJ/mol. The same experiments were performed for **3**, and similar behavior was observed upon irradiation ([Figure S24](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)). Eyring analysis of the THI afforded a Δ^⧧^*G* (20 °C) of 83.9 ± 1 kJ/mol ([Figure S40](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)), which is also in agreement with the DFT-predicted value (Δ^⧧^*G*~calc~ (20 °C) = 87.4 kJ/mol). In the CD absorption spectrum, the *M* helicity of (*S*,*S*)-**2** gave rise to a positive Cotton effect. The sign of the CD absorption inverts upon irradiation, consistent with the formation of the metastable (*P*)-(*S*,*S*)-**2** isomer ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b). The photochemical and thermal behavior of **2** was further investigated via ^1^H NMR spectroscopy. A solution of **2** in CD~2~Cl~2~ was irradiated with 365 nm light at −40 °C. Upon photoinduced conversion from the stable to the metastable form, the methyl groups, initially positioned in the pseudo axial conformation, adopt pseudoequatorial positions. This conformational change is apparent in the changes in the ^1^H NMR spectra, where H~a~ and H~b~ shift from 1.29 and 1.35 ppm to 1.49 and 1.57 ppm, respectively, as well as the concomitant shifts of protons H~c~ and H~d~ ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [Figure S19](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)).

![Changes in the ^1^H NMR spectrum of a solution of **2** in CD~2~Cl~2~ upon irradiation at 365 nm at −40 °C.](jo-2017-00852d_0004){#fig4}

The photostationary state (PSS) ratio at 365 nm was 81/19 (metastable:stable) by integration of the signals. Heating the sample to 30 °C leads to full conversion to the stable isomer ([Figure S20](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)). It must be noted that the thermal relaxation can, in principle, proceed via two pathways, i.e., the anticipated "forward" THI or a "backward" thermal *E*--*Z* isomerization (TEZI). Since the TEZI energy barrier is usually much higher,^[@ref17]^ and considering the good correlation between the calculated barrier for the THI and experimentally found Δ^⧧^*G*, it is most likely that the metastable isomer relaxes via the THI pathway. Nevertheless, to unequivocally prove that the introduction of a β substituent does not affect the unidirectionality of the rotary motion of this type motor, the TEZI pathway was excluded by experiment. To this end, a derivative of **2** was synthesized with a methoxy moiety in the lower half. Irradiation of stable (*Z*)-**18** in CD~2~Cl~2~ afforded a PSS mixture of 80:20 (metastable (*E*)-**18**/stable (*Z*)-**18**). ([Figure S21](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)). Heating the sample to 30 °C led to the full conversion of metastable (*E*)-**18** to stable (*E*)-**18** as shown by NMR analysis ([Figure S22](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.7b00852/suppl_file/jo7b00852_si_002.pdf)), thereby excluding any possible TEZI reaction ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}), since via the latter pathway the initial (*Z*)-**18** would have been reformed.

![Photochemical and Thermal Isomerization Behavior of **18**](jo-2017-00852d_0009){#sch5}

Conclusions {#sec3}
===========

Light-driven unidirectional molecular motors based on overcrowded alkenes are an important class of molecular motors holding great promise for their application in molecular machinery. The enantiopurity of these compounds is crucial in their application. Previously, it was found challenging to obtain enantiopure molecular motors, due to racemization of the α stereocenter of the chiral ketones used in the BK olefination reaction. To bypass this loss in optical purity, a new class of motors has been designed with an additional group in the β position. It was found that the introduction of a methyl group at the β position disfavors the epimerization of the α stereogenic center during the formation of the thioketone and the BK reaction, thereby allowing for their facile enantioselective synthesis. UV/vis, CD, and ^1^H NMR spectroscopy studies revealed that the introduction of this extra methyl group at the β position does not compromise the unidirectional rotation of the molecular motor. This strategy greatly improved accessibility to single enantiomers of second-generation molecular motors and facilitates the development of applications based on this class of rotary molecular motors.

Experimental Section {#sec4}
====================

General Remarks {#sec4.1}
---------------

All reagents were obtained from commercial sources and used as received without further purification. (*S*)-1-(Naphthalen-2-yl)ethan-1-ol was obtained from Sigma-Aldrich. Dry solvents were obtained from a MBraun solvent purification system. Column chromatography was performed on a Reveleris X2 flash chromatography system. TLC: silica gel 60, Merck, 0.25 mm. HRMS were recorded on an LTQ Orbitrap XL. NMR spectra were obtained using a Varian Mercury Plus (^1^H: 400 MHz, ^13^C: 100 MHz) or a Varian Innova (^1^H: 500 MHz) instrument in CDCl~3~, or CD~2~Cl~2~. Chemical shifts are reported in δ units (ppm) relative to the residual solvent signal of CDCl~3~ (^1^H NMR, δ 7.26 ppm; ^13^C NMR, δ 77.0 ppm) or CD~2~Cl~2~ (^1^H NMR, δ 5.32 ppm). For ^1^H NMR spectroscopy, the splitting pattern of peaks is designated as follows: s (singlet), d (doublet), t (triplet), (multiplet), br (broad), p (quintet), or dd (doublet of doublets). UV--vis absorption spectra were measured on a Hewlett-Packard 8453 diode array spectrometer in a 1 cm quartz cuvette. Dichloromethane used for spectroscopic studies was of spectroscopic grade (UVASOL, Merck). CD spectroscopy was performed on a JASCO J-810 spectropolarimeter. Enantiomeric ratios were determined by HPLC analysis using a Shimadzu LC-10ADVP HPLC equipped with a Shimadzu SPD-M10AVP diode array detector. Supercritical fluid chromatography (SFC) analysis was performed on a Thar Technologies, Inc. (Waters) Investigator II system. Irradiation experiments were performed using Thorlab LEDs (M365F1). Density functional theory (DFT) calculations were carried out with the Gaussian 09 program (rev. D.01) program package.^[@ref19]^ All of the calculations were performed on systems in the gas phase using the Becke's three-parameter hybrid functional^[@ref20]^ with the LYP correlation functional^[@ref21],[@ref22]^ (DFT B3LYP/6-31G(d,p)). Each geometry optimization was followed by a vibrational analysis to determine that a minimum or saddle point on the potential energy surface was found.

Synthetic Procedures {#sec4.2}
--------------------

### (*S*)-3-(Naphthalen-2-yl)butanoic Acid (**8**) {#sec4.2.1}

Trimethylphosphine (1 M in toluene, 11.6 mL, 11.6 mmol) and diisopropyl azodicarboxylate were added dropwise (2.35 g, 11.61 mmol) to a solution of (*S*)-1-(naphthalen-2-yl)ethan-1-ol (1.00 g, 5.81 mmol) and triethyl methanetricarboxylate (2.70 g, 11.61 mmol) in toluene (10 mL) at 0 °C, and the mixture was subsequently stirred for 16 h at rt. EtOAc (20 mL) was added, and the organic layer was washed with water (40 mL), an aqueous solution of HCl (1 M, 40 mL), and brine (40 mL), dried over Na~2~SO~4~, and concentrated in vacuo. The obtained product was dissolved in EtOH (10 mL), and an aqueous solution of NaOH (3 M, 3 mL) was added. The reaction mixture was heated at reflux for 16 h and subsequently concentrated in vacuo. EtOAc (20 mL) was added to the crude product followed by an aqueous solution of HCl (2M, 20 mL). The organic layer was washed with brine, dried over Na~2~SO~4~, and reduced in vacuo. The crude product was dissolved in acetic acid, heated at reflux for 16 h, reduced in vacuo, and purified by column chromatography (SiO~2~, pentane/EtOAc) to afford **8** as a white solid (846 mg, 3.95 mmol, 68%): mp 65--68 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 11.23 (br, 1H), 7.93--7.79 (m, 3H), 7.79--7.64 (m, 1H), 7.61--7.45 (m, 2H), 7.42 (dd, *J* = 8.5, 1.8 Hz, 1H), 3.50 (h, *J* = 7.1 Hz, 1H), 2.86--2.67 (m, 2H), 1.45 (d, *J* = 7.0 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 178.9, 142.8, 133.5, 132.3, 128.2, 127.6, 127.6, 126.0, 125.4, 125.3, 124.9, 42.5, 36.2, 21.8; HRMS (ESI−) calcd for C~14~H~13~O~2~ \[M -- H\]^−^ 231.0910, found 231.0923.

### (*S*)-3-Methyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-one (**9**) {#sec4.2.2}

TfOH (5 mL) was added to a solution of acid **8** (800 mg, 3.73 mmol) in CH~2~Cl~2~ (5 mL) at 0 °C. The reaction mixture was stirred for 0.5 h at 0 °C and subsequently quenched by the addition of ice. EtOAc (25 mL) was added, and the organic layer was washed with a saturated solution of NaHCO~3~ (aq) (2 × 30 mL) and brine (30 mL), dried over Na~2~SO~4~, and concentrated in vacuo. The crude product was purified by column chromatography to afford **9** as a white solid (583 mg, 2.98 mmol, 80%): mp 76--79 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 9.15 (d, *J* = 8.4 Hz, 1H), 7.96 (d, *J* = 8.4 Hz, 1H), 7.81 (d, *J* = 8.2 Hz, 1H), 7.62 (t, *J* = 7.5 Hz, 1H), 7.49 (t, *J* = 7.5 Hz, 1H), 7.45 (d, *J* = 8.4 Hz, 1H), 3.39 (ddt, *J* = 11.1, 6.9, 4.0 Hz, 1H), 2.98 (dd, *J* = 18.8, 7.2 Hz, 1H), 2.33 (dd, *J* = 18.8, 3.0 Hz, 1H), 1.38 (d, *J* = 7.2 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 206.6, 162.6, 135.6, 132.3, 129.9, 128.9, 128.6, 127.8, 126.3, 123.8, 122.3, 45.7, 32.5, 20.9; HRMS (APCI+) calcd for C~14~H~13~O \[M + H\]^+^ 197.0961, found 197.0963; Chiralpak ID column, CO~2~/CH~3~OH 90:10, 4.0 mL/min, 40 °C, 150 bar, retention times (min) 2.57 (major), 2.77 (minor).

### (2*S*,3*S*)-2,3-Dimethyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-one (**10**) (Mixture of Cis and Trans) {#sec4.2.3}

A solution of *n*-BuLi (1.6 M, 2.1 mL, 3.36 mmol) was added to a solution of NH(*i*-Pr)~2~ (340 mg, 3.36 mmol) in THF (10 mL) at 0 °C, and the solution was stirred for 0.5 h. The solution was cooled to −78 °C, and a solution of ketone **9** (641 mg, 3.27 mmol) in THF (10 mL) was added dropwise via a syringe. The reaction mixture was stirred for 0.5 h. To the reaction mixture was added CH~3~I (1.62 g 11.41 mmol), after which the cooling bath was removed. The reaction mixture was stirred for 16 h and quenched with a saturated solution of NH~4~Cl (aq) (20 mL). EtOAc (50 mL) was added, and the organic layer was washed with a saturated solution of NaCl (aq) (3 × 50 mL), dried over Na~2~SO~4~, and concentrated in vacuo. The crude product was purified by column chromatography (SiO~2~, pentane/EtOAc) to afford ketone (*S*,*S*)-**10** (cis/trans 10/90) as a white solid (529 mg, 2.52 mmol, 77% yield): ^1^H NMR (400 MHz, CDCl~3~) δ 9.15 (d, *J* = 8.4 Hz, 1H), 8.07 (d, *J* = 8.4 Hz, 1H), 7.89 (d, *J* = 8.6 Hz, 1H), 7.76--7.61 (m, 1H), 7.61--7.46 (m, 2H), 3.60 (p, *J* = 7.4 Hz, 1H) (minor), 3.03 (qd, *J* = 7.1, 3.7 Hz, 1H), 2.94 (p, *J* = 7.3 Hz, 1H) (minor), 2.36 (qd, *J* = 7.4, 3.9 Hz, 1H), 1.51 (dd, *J* = 7.1, 0.7 Hz, 3H), 1.38 (d, *J* = 7.4 Hz, 3H), 1.32--1.27 (m, 6H) (minor); ^13^C NMR (101 MHz, CDCl~3~) δ 208.9, 160.5, 135.8, 132.6, 129.6, 129.3, 128.9, 128.0, 126.5, 124.2, 122.2, 51.7, 41.8, 19.3, 14.7; HRMS (ESI+) calcd for C~15~H~15~O \[M + H\]^+^ 211.1117 found 211.1118.

### (2*S*,3*S*)-2-Isopropyl-3-methyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-one (**11**) {#sec4.2.4}

A solution of *n*-BuLi (1.6 M, 2.0 mL, 3.23 mmol) was added to a solution of NH(*i*-Pr)~2~ (327 mg, 3.23 mmol) in THF (10 mL) at 0 °C, and the solution was stirred for 0.5 h. The solution was cooled to −78 °C, and a solution of ketone **9** (576 mg, 2.94 mmol) in THF (10 mL) was added dropwise via a syringe. The solution was stirred for 0.5 h. To the reaction mixture were added HMPA (527 mg, 2.94 mmol) and *i*-PrI (1.5 g 8.82 mmol), after which the mixture was allowed to warm to room temperature. The reaction mixture was stirred for 16 h and quenched with a saturated solution of NH~4~Cl (aq) (20 mL). EtOAc (50 mL) was added, and the organic layer was washed with brine (3 × 50 mL), dried over Na~2~SO~4~, and concentrated in vacuo. The crude product was purified by column chromatography (SiO~2~, pentane/EtOAc) to afford ketone **11** as a light yellow oil. (431 mg, 1.81 mmol, 62% yield): ^1^H NMR (400 MHz, CDCl~3~) δ 9.20 (d, *J* = 8.4 Hz, 1H), 8.06 (d, *J* = 8.4 Hz, 1H), 7.88 (d, *J* = 8.2 Hz, 1H), 7.70--7.64 (m, 1H), 7.59--7.51 (m, 2H), 3.28 (qd, *J* = 7.1, 3.0 Hz, 1H), 2.50 (pd, *J* = 6.9, 4.3 Hz, 1H), 2.33 (dd, *J* = 4.3, 3.0 Hz, 1H), 1.47 (d, *J* = 7.1 Hz, 3H), 1.14 (d, *J* = 7.0 Hz, 3H), 0.86 (d, *J* = 6.8 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 208.9, 161.9, 135.8, 132.6, 130.4, 129.1, 128.9, 128.0, 126.5, 124.2, 122.5, 62.1, 35.2, 29.5, 21.6, 20.9, 17.9; HRMS (APCI+) calcd for C~17~H~19~O \[M + H\]^+^ 239.1430, found 239.1435.

### 2,7-Dibromo-9-((2*S*,3*S*)-2,3-dimethyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-ylidene)-9*H*-fluorene (**15**) {#sec4.2.5}

A two-neck flask was charged with Lawesson's reagent (2.31 g, 5.71 mmol). A solution of **10** (400 mg, 1.90 mmol, 96% ee, 90:10 dr) in toluene (20 mL) was added, and the resulting suspension was heated at 100 °C for 4 h, after which it was cooled to room temperature. The suspension was filtered over a plug of cotton. The filtrate was reduced in vacuo and purified by column chromatography (SiO~2~, pentane/CH~2~Cl~2~). The thioketone was obtained diastereomerically pure in 60% yield and was added to a solution of 2,7-dibromo-9-diazo-9*H*-fluorene (525 mg, 1.50 mmol) in THF (10 mL). The reaction mixture was stirred for 40 h, subsequently concentrated in vacuo, and purified by column chromatography (SiO~2~, pentane/CH~2~Cl~2~). The obtained mixture of episulfide and alkene was dissolved in THF (5 mL), treated with tris(dimethylamino)phosphine (2.00 mmol, 326 mg), and stirred for 16 h to afford, after purification by column chromatography (SiO~2~, pentane/CH~2~Cl~2~), **15** as a yellow solid (401 mg, 0.78 mmol, 68% yield over two steps, 96% ee). Recrystallization from heptane afforded **15** enantiomerically pure: mp 192--195 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.07 (d, *J* = 1.6 Hz, 1H), 8.01--7.95 (m, 2H), 7.68 (d, *J* = 8.1 Hz, 1H), 7.64--7.61 (m, 1H), 7.59 (t, *J* = 7.8 Hz, 2H), 7.56--7.50 (m, 2H), 7.43--7.37 (m, 1H), 7.35 (dd, *J* = 8.1, 1.7 Hz, 1H), 6.79 (d, *J* = 1.7 Hz, 1H), 3.84 (q, *J* = 6.7 Hz, 1H), 3.15 (q, *J* = 7.0 Hz, 1H), 1.44 (d, *J* = 6.8 Hz, 3H), 1.38 (d, *J* = 7.0 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 153.6, 153.5, 141.4, 138.3, 137.8, 137.2, 134.2, 132.8, 132.2, 129.7, 129.6, 129.5, 129.3, 129.0, 129.0, 127.1, 127.0, 126.9, 125.6, 123.2, 121.1, 120.9, 120.1, 120.1, 52.9, 49.5, 21.5, 19.3; HRMS (APCI+) calcd for C~28~H~21~Br~2~ \[M + H\]^+^ 516.9984, found 516.9987; Chiracel AD-H column, *n*-heptane/*i*-PrOH 95:5, 0.5 mL/min, 40 °C, retention times (min) 8.00 ((*R*,*R*)-**15**), 8.95 ((*S*,*S*)-**15**).

### 2,7-Dibromo-9-((2*S*,3*S*)-2-isopropyl-3-methyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1ylidene)-9*H* fluorine (**17**) {#sec4.2.6}

A two-neck flask was charged with Lawesson's reagent (1.272 g, 3.15 mmol). A solution of **11** (250 mg, 1.05 mmol, 96% ee) in toluene (15 mL) was added, and the resulting suspension was heated at reflux for 3 h. The suspension was filtered over a plug of cotton. The filtrate was reduced in vacuo and purified by column chromatography (SiO~2~, pentane/CH~2~Cl~2~). The obtained thioketone was added to a solution of 2,7-dibromo-9-diazo-9*H*-fluorene (350 mg, 1.00 mmol) in THF (10 mL). The reaction mixture was stirred for 40 h, subsequently reduced in vacuo, and purified by column chromatography (SiO~2~, pentane/CH~2~Cl~2~). The obtained mixture of episulfide and alkene was dissolved in THF (5 mL), treated with tris(dimethylamino)phosphine (2.00 mmol, 326 mg), and stirred for 16 h to afford, after purification by column chromatography (SiO~2~, pentane/CH~2~Cl~2~), **17** as a yellow solid (137 mg, 0.25 mmol, 24% yield over three steps, 96% ee). Recrystallization from heptane afforded **17** with an enantiopurity of 99% ee: mp 118--120 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.12 (d, *J* = 1.6 Hz, 1H), 7.99--7.94 (m, 2H), 7.67 (d, *J* = 8.1 Hz, 1H), 7.63 (d, *J* = 8.4 Hz, 1H), 7.58 (d, *J* = 8.1 Hz, 1H), 7.56--7.49 (m, 3H), 7.43--7.37 (m, 1H), 7.35 (dd, *J* = 8.1, 1.8 Hz, 1H), 6.78 (d, *J* = 1.7 Hz, 1H), 3.69 (d, *J* = 5.1 Hz, 1H), 3.35 (q, *J* = 7.0 Hz, 1H), 2.25 (m, 1H), 1.41 (d, *J* = 7.0 Hz, 3H), 1.20 (d, *J* = 7.0 Hz, 3H), 0.67 (d, *J* = 6.7 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 154.1, 152.7, 141.3, 138.3, 137.9, 137.1, 135.8, 132.7, 132.1, 129.9, 129.6, 129.5, 129.1, 129.0, 128.7, 127.5, 127.0, 126.9, 125.6, 122.4, 120.8, 120.8, 120.1, 119.9, 63.9, 43.6, 31.5, 21.7, 20.6, 18.9; HRMS (APCI+) calcd for C~30~H~25~Br~2~ \[M + H\]^+^ 545.0297, found 545.0301; Chiracel AD-H column, *n*-heptane/*i*-PrOH 95:5, 0.5 mL/min, 40 °C, retention times (min) 7.29 ((*R*,*R*)**-17**), 7.88 ((*S*,*S*)-**17**).

### 9-(2*S*,3*S*)-(2,3-Dimethyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-ylidene)-9*H*-fluorene (**2**) {#sec4.2.7}

A solution of *n*-BuLi in hexanes (1.6M, 0.75 mL, 1.2 mmol) was added dropwise to a solution of **15** (100 mg, 0.19 mmol) in THF (5 mL) at −78 °C via a syringe. The resulting solution was stirred for 15 min, after which CH~3~OH (5 mL) was added. The reaction mixture was heated to room temperature, reduced in vacuo, and purified by column chromatography to afford **2** (55 mg, 0.15 mmol, 79% yield) as a yellow foam: ^1^H NMR (400 MHz, CDCl~3~) δ 8.01--7.96 (m, 1H), 7.94 (dd, *J* = 8.2, 4.3 Hz, 2H), 7.90--7.85 (m, 1H), 7.78 (dd, *J* = 8.1, 4.1 Hz, 2H), 7.57 (d, *J* = 8.2 Hz, 1H), 7.51--7.44 (m, 1H), 7.43--7.37 (m, 2H), 7.32 (t, *J* = 7.6 Hz, 1H), 7.24 (t, *J* = 7.4 Hz, 1H), 6.87--6.80 (m, 1H), 6.80--6.74 (m, 1H), 3.91 (q, *J* = 6.7 Hz, 1H), 3.11 (q, *J* = 7.0 Hz, 1H), 1.42 (d, *J* = 6.7 Hz, 3H), 1.37 (d, *J* = 7.0 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 152.7, 150.1, 140.1, 139.9, 139.5, 137.1, 135.3, 132.8, 131.9, 131.0, 129.9, 128.6, 127.6, 126.9, 126.9, 126.8, 126.5, 125.9, 125.8, 125.3, 124.0, 123.3, 119.7, 118.9, 53.1, 49.4, 21.5, 19.3; HRMS (APCI+) calcd for C~28~H~23~ \[M + H\]^+^ 359.1794, found 359.1790.

### 9-((2*S*,3*S*)-2-Isopropyl-3-methyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-ylidene)-9*H*-fluorene (**3**) {#sec4.2.8}

A solution of *n*-BuLi in hexanes (1.6M, 0.5 mL, 0.8 mmol) was added dropwise to a solution of **17** (80 mg, 0.15 mmol) in THF (5 mL) at −78 °C via a syringe. The resulting solution was stirred for 15 min, after which CH~3~OH (5 mL) was added. The reaction mixture was heated to room temperature, reduced in vacuo, and purified by column chromatography to afford **3** (43 mg, 0.11 mmol, 75% yield) as a yellow foam: ^1^H NMR (400 MHz, CDCl~3~) δ 8.04--7.98 (m, 1H), 7.97--7.90 (m, 2H), 7.90--7.85 (m, 1H), 7.81--7.75 (m, 2H), 7.53 (d, *J* = 8.2 Hz, 1H), 7.49--7.44 (m, 1H), 7.44--7.38 (m, 2H), 7.36--7.30 (m, 1H), 7.26--7.20 (m, 1H), 6.83--6.74 (m, 2H), 3.78 (d, *J* = 5.3 Hz, 1H), 3.33 (q, *J* = 7.0 Hz, 1H), 2.33--2.23 (m, 1H), 1.41 (d, *J* = 7.0 Hz, 3H), 1.19 (d, *J* = 7.0 Hz, 3H), 0.67 (d, *J* = 6.7 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 153.2, 149.4, 140.3, 139.9, 139.4, 137.1, 136.9, 132.6, 132.5, 130.9, 129.1, 128.7, 127.4, 126.9, 126.8, 126.7, 126.5, 125.9, 125.9, 125.3, 124.2, 122.5, 119.6, 118.8, 64.1, 43.6, 31.4, 21.6, 20.7, 19.1; HRMS (APCI+) calcd for C~30~H~27~ \[M + H\]^+^ 387.2107, found 387.2110

### (±)-(*Z*)-9-(2,3-Dimethyl-2,3-dihydro-1*H*-cyclopenta\[*a*\]naphthalen-1-ylidene)-2-methoxy-9*H*-fluorene (**18**) {#sec4.2.9}

A two-neck flask was charged with Lawesson's reagent (2.305 g, 5.70 mmol). A solution of (±)-**10** (400 mg, 1.90 mmol, 90:10 dr) in toluene (20 mL) was added, and the resulting suspension was heated at 100 °C for 4 h. The suspension was filtered over a plug of cotton. The filtrate was reduced in vacuo and purified by column chromatography (SiO~2~, pentane/CH~2~Cl~2~). The thioketone was obtained diastereomerically pure in 60% yield and was added to a solution of 9-diazo-2-methoxy-9*H*-fluorene (667 mg, 3.00 mmol) in THF (10 mL). The reaction mixture was stirred for 40 h, subsequently concentrated in vacuo, and purified by column chromatography (SiO~2~, pentane/CH~2~Cl~2~). The obtained mixture of episulfide and alkene was dissolved in THF (10 mL), treated with tris(dimethylamino)phosphine (2.00 mmol, 326 mg), and stirred for 16 h to afford after purification by column chromatography (SiO~2~, pentane/CH~2~Cl~2~) **18** (248 mg, 0.64 mmol 56% yield over two steps) as a yellow solid (mixture of *E* and *Z* isomers). Recrystallization from ethanol afforded (*Z*)-**20**: mp 159--162 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.96--7.89 (m, 3H), 7.80 (d, *J* = 8.4 Hz, 1H), 7.77--7.72 (m, 1H), 7.63 (d, *J* = 8.3 Hz, 1H), 7.57 (d, *J* = 8.2 Hz, 1H), 7.49--7.42 (m, 1H), 7.41--7.29 (m, 3H), 6.80 (dd, *J* = 8.3, 2.4 Hz, 1H), 6.32 (d, *J* = 2.3 Hz, 1H) 3.90 (q, *J* = 6.8 Hz, 1H), 3.11 (q, *J* = 7.0 Hz, 1H), 2.99 (s, 3H), 1.43 (d, *J* = 6.7 Hz, 3H), 1.38 (d, *J* = 7.0 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 158.3, 152.7, 150.0, 140.3, 139.7, 138.4, 135.1, 132.8, 132.7, 132.0, 131.0, 129.7, 128.7, 127.9, 127.0, 126.6, 125.7, 125.2, 123.9, 123.4, 119.6, 118.9, 115.0, 110.0, 54.4, 52.8, 49.4, 21.4, 19.2; HRMS (ESI+) calcd for C~29~H~25~O \[M + H\]^+^ 389.1900, found 389.1902.
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